Literature DB >> 32535979

The red half-moon nail sign: a novel manifestation of coronavirus infection.

I Neri1, A Guglielmo1, A Virdi1, V Gaspari1, M Starace1, B M Piraccini1.   

Abstract

Entities:  

Year:  2020        PMID: 32535979      PMCID: PMC7323324          DOI: 10.1111/jdv.16747

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


× No keyword cloud information.
Editor The novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is the causative agent of the coronavirus disease 2019 (COVID‐19). The pandemic condition was declared by the WHO on 11 March 2020. The main clinical symptoms are fever, dry cough and dyspnoea, although new symptoms are emerging, such as diarrhoea, anosmia and ageusia. The virus enters cells, likely including those lining blood vessels, by binding to angiotensin‐converting enzyme 2 (ACE2) receptors on the cell surface. Infection can also promote blood clots, heart attacks and cardiac inflammation. In the literature, some dermatological manifestations have recently been reported, such as erythematous, vesiculous and urticarial rashes. , , However, there are no data about nail signs occurring during COVID 19. A 60‐year‐old otherwise healthy woman presented with a history of fever (>38°C) and cough. Seven days after the onset of these symptoms the patient referred dyspnoea, associated with anosmia and ageusia. Although chest X‐ray examination was normal, chest CT revealed ground‐glass opacity, leading to a diagnosis of bilateral interstitial pneumonia. A positive RT‐PCR nasopharyngeal swab confirmed SARS‐CoV‐2 infection. The patient was hospitalized and underwent oxygen therapy together with administration of several drugs, including hydroxychloroquine, lopinavir/ritonavir, ceftriaxone and heparin. Complete remission of respiratory symptoms, associated with negative nasopharyngeal swab was seen 10 days after the treatment was started. Two weeks after symptoms onset, a distally convex half‐moon‐shaped red band surrounding the distal margin of the lunula appeared on all fingernails (Fig. 1). The patient denied any associated symptoms, and no other skin manifestations were observed. Her dermatological medical history was unremarkable. After one month of follow‐up, the bands are still present and wider (Fig. 2).
Figure 1

Distally convex half‐moon‐shaped red bands surrounding the distal margin of the lunula.

Figure 2

The half‐moon‐shaped red bands are still present after 1 month of follow‐up on all fingernails and appear wider.

Distally convex half‐moon‐shaped red bands surrounding the distal margin of the lunula. The half‐moon‐shaped red bands are still present after 1 month of follow‐up on all fingernails and appear wider. Polydactylous erythronychia differential diagnosis includes lichen planus, Darier’s disease and the more rare primary amyloidosis and graft‐versus‐host disease. In all these conditions, however, erythronychia is arranged in longitudinal lines, while in our case erythronychia has an half‐moon shape margining the lunula. Transversal red bands of the nail were reported for the first time by Lindsley in four patients affected by Kawasaki disease. Unlike our case, however, in those patients the bands were localized in the distal part of the nail bed, in the so‐called nail isthmus. The pathogenesis of the half‐moon‐shaped transversal red bands seen in our patient after SARS‐CoV‐2 infection is unknown. A localized microvascular injury secondary to inflammatory immune response and a procoagulant state might play a central role. Due to the localization, we hypothesized a damage of the capillary network of the distal subungual arcade. To the best of our knowledge, this is the first case of nail involvement. This sign is peculiar and has not been previously described even in dermatological or systemic diseases. Further studies are needed to validate our finding and to assess whether red half‐moon nail could represent a pathognomic sign of COVID19.

Conflict of interest

Dr. Neri, Dr. Guglielmo, Dr. Virdi, Dr. Gaspari, Dr. Starace and Dr. Piraccini have nothing to disclose.

Funding source

None.
  7 in total

1.  Nail-bed lines in Kawasaki disease.

Authors:  C B Lindsley
Journal:  Am J Dis Child       Date:  1992-06

2.  A rampage through the body.

Authors:  Meredith Wadman; Jennifer Couzin-Frankel; Jocelyn Kaiser; Catherine Matacic
Journal:  Science       Date:  2020-04-24       Impact factor: 47.728

Review 3.  Longitudinal erythronychia: suggestions for evaluation and management.

Authors:  Nathaniel J Jellinek
Journal:  J Am Acad Dermatol       Date:  2010-08-14       Impact factor: 11.527

4.  Cutaneous manifestations in COVID-19: a first perspective.

Authors:  S Recalcati
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05       Impact factor: 6.166

5.  Varicella-like exanthem as a specific COVID-19-associated skin manifestation: Multicenter case series of 22 patients.

Authors:  Angelo Valerio Marzano; Giovanni Genovese; Gabriella Fabbrocini; Paolo Pigatto; Giuseppe Monfrecola; Bianca Maria Piraccini; Stefano Veraldi; Pietro Rubegni; Marco Cusini; Valentina Caputo; Franco Rongioletti; Emilio Berti; Piergiacomo Calzavara-Pinton
Journal:  J Am Acad Dermatol       Date:  2020-04-16       Impact factor: 11.527

6.  Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.

Authors:  Cynthia Magro; J Justin Mulvey; David Berlin; Gerard Nuovo; Steven Salvatore; Joanna Harp; Amelia Baxter-Stoltzfus; Jeffrey Laurence
Journal:  Transl Res       Date:  2020-04-15       Impact factor: 7.012

Review 7.  Urticarial eruption in COVID-19 infection.

Authors:  D Henry; M Ackerman; E Sancelme; A Finon; E Esteve
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06       Impact factor: 9.228

  7 in total
  19 in total

1.  Fluorescence in the Sclera, Nails, and Teeth Secondary to Favipiravir Use for COVID-19 Infections.

Authors:  Emel Öztürk Durmaz; Deniz Demircioğlu
Journal:  J Clin Aesthet Dermatol       Date:  2022-03

Review 2.  Nails and COVID-19 - A comprehensive review of clinical findings and treatment.

Authors:  Uwe Wollina; Jean Kanitakis; Robert Baran
Journal:  Dermatol Ther       Date:  2021-08-22       Impact factor: 3.858

3.  Yellow-white fluorescence on the nails: A novel finding of Favipiravir used for the treatment of COVID-19.

Authors:  Duygu Gülseren; Başak Yalıcı-Armagan
Journal:  J Cosmet Dermatol       Date:  2021-05-31       Impact factor: 2.189

4.  Heterogeneous red-white discoloration of the nail bed and distal onycholysis in a patient with COVID-19.

Authors:  B Demir; E I Yuksel; D Cicek; S Turkoglu
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-05-28       Impact factor: 9.228

Review 5.  Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature.

Authors:  Gürkan Kaya; Aysin Kaya; Jean-Hilaire Saurat
Journal:  Dermatopathology (Basel)       Date:  2020-06-30

6.  Transverse orange nail lesions following SARS-CoV-2 infection.

Authors:  Antonella Tammaro; Ganiyat Adenike Ralitsa Adebanjo; Hans-Peter Erasmus; Camilla Chello; Aldo Pezzuto; Sergio Ramirez-Estrada; Jordi Rello
Journal:  Dermatol Ther       Date:  2020-12-22       Impact factor: 3.858

7.  Multiple retronychia following COVID-19 infection.

Authors:  Miguel A Ceccarelli; Robertha C Nakamura; Clarissa Canella
Journal:  Vis J Emerg Med       Date:  2021-07-14

Review 8.  Skin disorders associated with the COVID-19 pandemic: A review.

Authors:  Jennifer Akl; Jessica El-Kehdy; Antoine Salloum; Anthony Benedetto; Paula Karam
Journal:  J Cosmet Dermatol       Date:  2021-07-01       Impact factor: 2.189

Review 9.  Cutaneous manifestations of COVID-19 in children (and adults): A virus that does not discriminate.

Authors:  Michael Joseph Lavery; Charles Alexis Bouvier; Ben Thompson
Journal:  Clin Dermatol       Date:  2020-11-01       Impact factor: 3.541

10.  Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations.

Authors:  Rattapon Thuangtong; Nasikarn Angkasekwinai; Charussri Leeyaphan; Daranporn Triwongwaranat; Kanchalit Thanomkitti; Kanyalak Munprom; Kanokvalai Kulthanan
Journal:  Biomed Res Int       Date:  2021-06-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.